mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.05 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.05 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.06 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.06 |